Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects
Clinical trial NCT04671017 · COMPLETED
Trial details
- NCT number
- NCT04671017
- Sponsor
- Valneva Austria GmbH
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2021-02-26
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.